KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Jazz Pharmaceuticals (JAZZ) Inventory Average: 2009-2025

Historic Inventory Average for Jazz Pharmaceuticals (JAZZ) over the last 17 years, with Sep 2025 value amounting to $494.1 million.

  • Jazz Pharmaceuticals' Inventory Average fell 8.67% to $494.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $494.1 million, marking a year-over-year decrease of 8.67%. This contributed to the annual value of $538.7 million for FY2024, which is 17.82% down from last year.
  • According to the latest figures from Q3 2025, Jazz Pharmaceuticals' Inventory Average is $494.1 million, which was down 0.97% from $498.9 million recorded in Q2 2025.
  • In the past 5 years, Jazz Pharmaceuticals' Inventory Average ranged from a high of $1.2 billion in Q3 2021 and a low of $105.4 million during Q1 2021.
  • In the last 3 years, Jazz Pharmaceuticals' Inventory Average had a median value of $559.9 million in 2024 and averaged $570.6 million.
  • In the last 5 years, Jazz Pharmaceuticals' Inventory Average skyrocketed by 1,198.87% in 2021 and then plummeted by 34.76% in 2022.
  • Quarterly analysis of 5 years shows Jazz Pharmaceuticals' Inventory Average stood at $1.1 billion in 2021, then tumbled by 34.76% to $721.1 million in 2022, then decreased by 16.18% to $604.4 million in 2023, then fell by 15.64% to $509.9 million in 2024, then fell by 8.67% to $494.1 million in 2025.
  • Its Inventory Average stands at $494.1 million for Q3 2025, versus $498.9 million for Q2 2025 and $486.6 million for Q1 2025.